GE HealthCare (GEHC) revenue and earnings history
GE HealthCare reported revenue of $20.6B for fiscal 2025 (year ended Dec 31, 2025), +4.8% on the year before, and net income of $2.08B.
Over 4 years, from fiscal 2021 to fiscal 2025, revenue grew at a compound rate of +4.1% a year.
Revenue and net income, 5 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $20.6B+4.8% | $2.76B | $2.08B | $1.99B | $482M | $1.5B | $130M | $200M | $64M | $4.49B | $10B | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: GE HealthCare (GEHC) on OQRO.
Common questions
What was GE HealthCare's revenue in fiscal 2025?
$20.6B for the year ended Dec 31, 2025, as reported in its 10-K filed Feb 4, 2026. That is +4.8% on fiscal 2024 ($19.7B).
How fast has GE HealthCare's revenue grown?
From $17.6B in fiscal 2021 to $20.6B in fiscal 2025: a compound annual growth rate of +4.1% over 4 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure GE HealthCare tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
